146 related articles for article (PubMed ID: 17502397)
1. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004.
de Filippis I; de Andrade CF; Silva L; Prevots DR; Vicente AC
Infect Immun; 2007 Jul; 75(7):3683-5. PubMed ID: 17502397
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.
Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A
J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914
[TBL] [Abstract][Full Text] [Related]
3. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine.
Sorhouet Pereira C; Regueira M; Mollerach M
J Med Microbiol; 2008 Mar; 57(Pt 3):338-342. PubMed ID: 18287297
[TBL] [Abstract][Full Text] [Related]
4. Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.
Dyet KH; Martin DR
J Clin Microbiol; 2005 Feb; 43(2):838-42. PubMed ID: 15695689
[TBL] [Abstract][Full Text] [Related]
5. Stability of PorA during a meningococcal disease epidemic.
Devoy AF; Dyet KH; Martin DR
J Clin Microbiol; 2005 Feb; 43(2):832-7. PubMed ID: 15695688
[TBL] [Abstract][Full Text] [Related]
6. Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
Clarke SC; Diggle MA; Mölling P; Unemo M; Olcén P
Vaccine; 2003 Jun; 21(19-20):2468-73. PubMed ID: 12744880
[TBL] [Abstract][Full Text] [Related]
7. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.
Sacchi CT; Lemos AP; Popovic T; De Morais JC; Whitney AM; Melles CE; Brondi LM; Monteiro LM; Paiva MV; Solari CA; Mayer LW
J Clin Microbiol; 2001 Aug; 39(8):2897-903. PubMed ID: 11474010
[TBL] [Abstract][Full Text] [Related]
8. Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.
Zhou J; Lefebvre B; Deng S; Gilca R; Deceuninck G; Law DK; De Wals P; Tsang RS
J Clin Microbiol; 2012 May; 50(5):1545-51. PubMed ID: 22337990
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of meningococcal disease caused by PorA-deficient meningococci.
van der Ende A; Hopman CT; Keijzers WC; Spanjaard L; Lodder EB; van Keulen PH; Dankert J
J Infect Dis; 2003 Mar; 187(5):869-71. PubMed ID: 12599063
[TBL] [Abstract][Full Text] [Related]
10. The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.
Climent Y; Urwin R; Yero D; Martinez I; Martín A; Sotolongo F; Maiden MC; Pajón R
Infect Genet Evol; 2010 May; 10(4):546-54. PubMed ID: 20156598
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of serogroup C Neisseria meningitidis isolated in China.
Zhang X; Shao Z; Yang E; Xu L; Xu X; Li M; Ren J; Zhu Y; Yang F; Liang X; Mayer LW; Xu J; Jin Q
J Med Microbiol; 2007 Sep; 56(Pt 9):1224-1229. PubMed ID: 17761487
[TBL] [Abstract][Full Text] [Related]
12. The VR2 epitope on the PorA P1.7-2,4 protein is the major target for the immune response elicited by the strain-specific group B meningococcal vaccine MeNZB.
Martin DR; Ruijne N; McCallum L; O'Hallahan J; Oster P
Clin Vaccine Immunol; 2006 Apr; 13(4):486-91. PubMed ID: 16603616
[TBL] [Abstract][Full Text] [Related]
13. Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.
Lucidarme J; Comanducci M; Findlow J; Gray SJ; Kaczmarski EB; Guiver M; Vallely PJ; Oster P; Pizza M; Bambini S; Muzzi A; Borrow R
Clin Vaccine Immunol; 2010 Jun; 17(6):919-29. PubMed ID: 20375242
[TBL] [Abstract][Full Text] [Related]
14. Genotypic characterization of Neisseria meningitidis serogroup B strains circulating in China.
Yang L; Shao Z; Zhang X; Xu L; Peng J; Xu X; Liang X; Qi Y; Jin Q
J Infect; 2008 Mar; 56(3):211-8. PubMed ID: 18215423
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.
Tsang RS; Tsai CM; Zhu P; Ringuette L; Lorange M; Law DK
J Clin Microbiol; 2004 Apr; 42(4):1460-5. PubMed ID: 15070989
[TBL] [Abstract][Full Text] [Related]
16. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.
Sacchi CT; Whitney AM; Popovic T; Beall DS; Reeves MW; Plikaytis BD; Rosenstein NE; Perkins BA; Tondella ML; Mayer LW
J Infect Dis; 2000 Oct; 182(4):1169-76. PubMed ID: 10979914
[TBL] [Abstract][Full Text] [Related]
17. Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009-2013.
Tsang RS; Hoang L; Tyrrell G; Horsman G; Wylie J; Jamieson FB; Lefebvre B; Taha MK
J Med Microbiol; 2015 Feb; 64(Pt 2):174-9. PubMed ID: 25627205
[TBL] [Abstract][Full Text] [Related]
18. Increase in serogroup C meningococcal disease in Canada is associated with antigenic changes in the protein antigens of the ET-15 clone of Neisseria meningitidis.
Tsang RS; Law DK; Henderson AM; Blake ML; Stoltz J
J Infect Dis; 2006 Dec; 194(12):1791-2; author reply 1792-3. PubMed ID: 17109354
[No Abstract] [Full Text] [Related]
19. Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001).
Caniça M; Dias R; Nunes B; Carvalho L; Ferreira E; The Meningococci Study Group
J Med Microbiol; 2004 Sep; 53(Pt 9):921-925. PubMed ID: 15314201
[TBL] [Abstract][Full Text] [Related]
20. Antigenic and/or phase variation of PorA protein in non-subtypable Neisseria meningitidis strains isolated in Spain.
Alcalá B; Salcedo C; Arreaza L; Abad R; Enríquez R; De La Fuente L; Uría MJ; Vázquez JA
J Med Microbiol; 2004 Jun; 53(Pt 6):515-518. PubMed ID: 15150331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
